These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7820779)

  • 41. Insufficiency of PTH action on bone in uremia.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    Kidney Int Suppl; 2006 Jul; (102):S34-6. PubMed ID: 16810309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.
    Miao D; He B; Lanske B; Bai XY; Tong XK; Hendy GN; Goltzman D; Karaplis AC
    Endocrinology; 2004 Apr; 145(4):2046-53. PubMed ID: 14701672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [PTH and bone metabolism in chronic dialysis patients].
    Fukagawa M; Kazama J; Shigematsu T
    Rinsho Byori; 2001 Mar; 49(3):236-8. PubMed ID: 11307321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal osteodystrophy and secondary hyperparathyroidism.
    Fukagawa M; Kazama JJ; Kurokawa K
    Nephrol Dial Transplant; 2002; 17 Suppl 10():2-5. PubMed ID: 12386262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
    Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
    Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mid C regional parathyroid hormone in the clinical workup: diagnostic value in extrarenal (primary) and renal (secondary) hyperparathyroidism].
    Jüppner H; Atkinson M; Ringe B; Krohn HP; Hesch RD
    Klin Wochenschr; 1986 Mar; 64(6):281-6. PubMed ID: 3520130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
    Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism.
    Togashi K; Takahashi N; Ando K; Tsukamoto Y; Marumo F
    Int J Artif Organs; 1990 Feb; 13(2):77-82. PubMed ID: 2347659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered response of adenylate cyclase to parathyroid hormone during compensatory renal growth.
    Milanes CL; Pernalete N; Starosta R; Perez-Gonzalez M; Paz-Martinez V; Bellorin-Font E
    Kidney Int; 1989 Nov; 36(5):802-9. PubMed ID: 2615189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
    Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
    Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K
    Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.